Discover 218 paid clinical trials in Morgantown, West Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 218
Active & Responsive
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
for
Idiopathic Hypersomnia
Location: Morgantown WV, Canton OH, Wyomissing PA,
Sponsor: Harmony Biosciences Management, Inc.
Sex: All
Age: 18+
Code: NCT07500090
Phase 3, Recruiting
Active & Responsive
EUS-Guided Ablation (RFA and MWA) for Pancreatic and Other Gastrointestinal Lesions Registry
for
RFA, Microwave Ablation, Pancreatic Lesion,
Location: Morgantown WV
Sponsor: West Virginia University
Sex: All
Age: 18+
Code: NCT07625189
Recruiting
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: Morgantown WV, Fredericksburg VA, Hamilton,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase 3, Recruiting
Active & Responsive
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
for
Kidney Disease
Location: Morgantown WV, Arlington VA, London, Cincinnati OH,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06963827
Phase 3, Recruiting
Active & Responsive
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer
for
Pancreatic Adenocarcinoma Non-resectable
Location: Morgantown WV, Ann Arbor MI
Sponsor: Continuity Biosciences, LLC
Sex: All
Age: 18+
Code: NCT07481383
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Morgantown WV, Bridgeport WV, Washington PA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase 3, Recruiting
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
for
Opioid Use Disorder, Opioid Use Disorder, Moderate,
Location: Morgantown WV, Huntington WV, Greenville SC, Chicago IL,
Sponsor: T. John Winhusen, PhD
Sex: All
Age: 18+
Code: NCT06651177
Phase 2, Recruiting
Active & Responsive
An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
for
Stomatitis
Location: Morgantown WV, Fairfax VA, Wynnewood PA, Lexington KY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07357597
Phase 4, Recruiting
Active & Responsive
Efficacy and Safety of Novosis Putty in Transforaminal Lumbar Interbody Fusion for Patients With Lumbar Degenerative Disc Disease
for
Degenerative Disc Disease
Location: Morgantown WV, Philadelphia PA, Little Rock AR,
Sponsor: CGBio Inc.
Sex: All
Age: 21 - 70+
Code: NCT07017634
Phase 3, Recruiting
Active & Responsive
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Uniontown PA, Washington PA, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06589804
Phase 3, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Cumberland MD, Westminster MD, Washington D.C. DC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase 3, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer